VERA
Price:
$34.26
Market Cap:
$2.46B
Vera Therapeutics, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of treatments for significant immunological disorders, primarily within the United States. Their leading therapeutic candidate is atacicept, a fusion protein that patients self-administer as a subcutaneous injection. This drug is currently undergoing Phase IIb clinical trials to treat immunoglobulin A nephropathy. The company is also advancing MAU868, a monoclonal antibody in Phase 2 clinical development, designed to combat BK viremia infections. Founded in 2016 and based in Brisbane, California, the organization operated as Trucode Gene Repair, Inc. until it rebranded to Vera T...[Read more]
Industry
Biotechnology
IPO Date
2021-05-14
Stock Exchange
NASDAQ
Ticker
VERA
According to Vera Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.42B. This represents a change of 5.01% compared to the average of 2.30B of the last 4 quarters.
The mean historical Enterprise Value of Vera Therapeutics, Inc. over the last ten years is 964.79M. The current 2.42B Enterprise Value has changed 24.98% with respect to the historical average. Over the past ten years (40 quarters), VERA's Enterprise Value was at its highest in in the December 2025 quarter at 2.98B. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.
Average
964.79M
Median
501.97M
Minimum
-11008252.00
Maximum
2.98B
Discovering the peaks and valleys of Vera Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 246.20%
Maximum Annual Enterprise Value = 2.98B
Minimum Annual Increase = -2682.16%
Minimum Annual Enterprise Value = -11008252.00
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 2.98B | 29.27% |
| 2024 | 2.30B | 246.20% |
| 2023 | 664.86M | 32.45% |
| 2022 | 501.97M | 76.59% |
| 2021 | 284.25M | -2682.16% |
| 2020 | -11008252.00 | -130.33% |
The current Enterprise Value of Vera Therapeutics, Inc. (VERA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
1.98B
5-year avg
1.35B
10-year avg
964.79M
Vera Therapeutics, Inc.’s Enterprise Value is greater than Celldex Therapeutics, Inc. (2.05B), greater than AbCellera Biologics Inc. (1.66B), greater than Janux Therapeutics, Inc. (796.69M), greater than Viridian Therapeutics, Inc. (1.35B), greater than Pharvaris N.V. (1.60B), greater than Immunome, Inc. (1.18B), greater than Biohaven Ltd. (1.21B), greater than uniQure N.V. (1.66B), greater than Harmony Biosciences Holdings, Inc. (1.61B), greater than Nuvation Bio Inc. (1.59B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 2.05B | $2.08B | |
| 1.66B | $1.60B | |
| 796.69M | $826.95M | |
| 1.35B | $1.47B | |
| 1.60B | $2.15B | |
| 1.18B | $1.76B | |
| 1.21B | $1.19B | |
| 1.66B | $1.74B | |
| 1.61B | $1.99B | |
| 1.59B | $1.71B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vera Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vera Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Vera Therapeutics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Vera Therapeutics, Inc. (VERA)?
What is the 3-year average Enterprise Value for Vera Therapeutics, Inc. (VERA)?
What is the 5-year average Enterprise Value for Vera Therapeutics, Inc. (VERA)?
How does the current Enterprise Value for Vera Therapeutics, Inc. (VERA) compare to its historical average?